Benjamin Solomon Selected Research

Benjamin Solomon Research Topics

Disease

48	Neoplasms (Cancer) 09/2022 - 01/2003
42	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2024 - 11/2005
15	Lung Neoplasms (Lung Cancer) 01/2022 - 10/2010
9	Squamous Cell Carcinoma of Head and Neck 11/2023 - 06/2011
8	Disease Progression 04/2024 - 12/2011
7	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2019 - 03/2003
6	Adenocarcinoma 08/2021 - 04/2009
6	Carcinoma (Carcinomatosis) 01/2021 - 04/2009
5	Thyroid Neoplasms (Thyroid Cancer) 01/2020 - 01/2012
4	Melanoma (Melanoma, Malignant) 01/2020 - 04/2012
3	Brain Neoplasms (Brain Tumor) 04/2024 - 11/2017
3	Mesothelioma 04/2024 - 01/2017
3	Breast Neoplasms (Breast Cancer) 11/2017 - 12/2005
3	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 09/2015 - 04/2011
2	Cataract (Cataracts) 10/2022 - 04/2022
2	COVID-19 01/2021 - 01/2020
2	Hyponatremia 01/2020 - 01/2020
2	Infections 01/2020 - 02/2017
2	medullary Thyroid cancer 01/2020 - 01/2012
2	Papillary Thyroid Cancer 01/2020 - 11/2019
2	Lymphopenia (Lymphocytopenia) 01/2020 - 10/2012
2	Hypertension (High Blood Pressure) 01/2020 - 01/2020
2	Adenocarcinoma of Lung 09/2017 - 04/2009
2	Hypoxia (Hypoxemia) 10/2015 - 09/2005
2	Prostatic Neoplasms (Prostate Cancer) 03/2015 - 08/2009
1	Cicatrix (Scar) 04/2022
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 10/2021
1	Hemolysis 08/2021

Drug/Important Bio-Agent (IBA)

16	Anaplastic Lymphoma KinaseIBA 08/2021 - 12/2009
12	Tyrosine Kinase InhibitorsIBA 11/2021 - 03/2003
11	ErbB Receptors (EGF Receptor)IBA 11/2021 - 09/2005
10	CrizotinibIBA 02/2017 - 10/2010
9	Biomarkers (Surrogate Marker)IBA 01/2019 - 06/2011
7	Cisplatin (Platino)FDA LinkGeneric 03/2019 - 11/2005
5	Phosphotransferases (Kinase)IBA 01/2022 - 04/2011
4	pembrolizumabIBA 04/2024 - 10/2018
4	PlatinumIBA 11/2023 - 09/2013
4	Proteins (Proteins, Gene)FDA Link 04/2019 - 03/2003
4	Gemcitabine FDA Link 03/2015 - 11/2005
3	NivolumabIBA 04/2024 - 01/2018
3	selpercatinibIBA 11/2023 - 01/2020
3	durvalumabIBA 01/2023 - 10/2018
3	AntigensIBA 01/2021 - 04/2009
3	Immune Checkpoint InhibitorsIBA 01/2020 - 01/2016
3	Alanine Transaminase (SGPT)IBA 01/2020 - 10/2012
3	Cell-Free Nucleic AcidsIBA 03/2018 - 01/2018
3	Carboplatin (JM8)FDA LinkGeneric 01/2017 - 05/2013
3	DNA (Deoxyribonucleic Acid)IBA 02/2014 - 12/2011
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 04/2011 - 09/2005
3	Gefitinib (Iressa)FDA Link 08/2009 - 03/2003
2	Cetuximab (Erbitux)FDA Link 11/2023 - 01/2017
2	Axitinib (AG 013736)IBA 01/2022 - 04/2021
2	larotrectinibIBA 01/2022 - 12/2021
2	CytokinesIBA 01/2022 - 04/2009
2	COVID-19 VaccinesIBA 05/2021 - 01/2021
2	Everolimus FDA Link 04/2021 - 12/2011
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2020 - 11/2019
2	vandetanib (ZD6474)IBA 01/2020 - 01/2012
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2020 - 01/2020
2	atezolizumabIBA 01/2020 - 10/2018
2	dabrafenibIBA 11/2019 - 04/2012
2	VemurafenibIBA 11/2019 - 04/2012
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2019 - 04/2012
2	ParaffinIBA 01/2016 - 08/2012
2	EnzymesIBA 10/2015 - 04/2009
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 03/2015 - 05/2011
2	Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA 12/2014 - 06/2013
2	DNA-Activated Protein KinaseIBA 02/2014 - 12/2011
2	Cyclin-Dependent Kinase Inhibitor p16IBA 08/2012 - 06/2011
2	Pemetrexed (MTA)FDA Link 12/2011 - 12/2005
1	IpilimumabIBA 04/2024
1	TabletsIBA 11/2023
1	AlpelisibIBA 11/2023
1	SuspensionsIBA 11/2023
1	osimertinibIBA 01/2023
1	Angiotensin-Converting Enzyme 2IBA 01/2022
1	avelumabIBA 01/2022
1	palbociclibIBA 01/2022
1	TropomyosinIBA 01/2022
1	Inducible T-Cell Co-Stimulator ProteinIBA 01/2022
1	repotrectinibIBA 12/2021
1	entrectinibIBA 12/2021
1	selitrectinibIBA 12/2021
1	alectinibIBA 08/2021
1	Nuclear Proteins (Protein, Nuclear)IBA 01/2021
1	epidermal growth factor receptor VIIIIBA 01/2021
1	VaccinesIBA 01/2021
1	depatuxizumabIBA 01/2021

Therapy/Procedure

30	Therapeutics 04/2024 - 01/2003
12	Radiotherapy 01/2023 - 09/2011
9	Drug Therapy (Chemotherapy) 10/2021 - 06/2007
7	Immunotherapy 04/2024 - 01/2016
2	Chemoradiotherapy 01/2023 - 05/2013
2	Radial Keratotomy 10/2022 - 04/2022
2	Lasers (Laser) 10/2022 - 04/2022
2	Molecular Targeted Therapy 01/2017 - 01/2012
2	Aftercare (After-Treatment) 08/2012 - 06/2007
2	Adjuvant Chemotherapy 06/2007 - 11/2005
1	Contact Lenses 01/2023